- Straits Times Index3,077.91-1.07%
- Nikkei21,219.50-2.12%
- Hang Seng25,745.461-1.22%
- FTSE 1006,778.11+1.10%
- BTC-USD3,529.87-1.75%
- S&P 5002,633.08-2.33%
- Dow24,388.95-2.24%
- Nasdaq6,969.25-3.05%
- Gold1,255.20+0.21%
- Crude Oil52.45-0.30%
- 10-Yr Bond2.8500-0.90%
- FTSE Bursa Malaysia1,663.69-1.00%
- Jakarta Composite Index6,096.09-0.49%
- PSE Index7,378.38-1.11%
Cannabis Stocks
39.41k followers • 23 symbols +5.41% Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
23 symbols
Get the Yahoo Finance app
- Free real-time data
- News and price alerts
- Add and edit holdings
- Track performance
- Create multiple watchlists
- Motley Fool•9 hours ago
Here's Why AbbVie Stock Surged 21.1% in November
Hints of success for the company's blood cancer pipeline encouraged investors last month.
- Motley Fool•14 hours ago
The Craziest Marijuana Statistic of 2018
Despite no shortage of cannabis milestones, it was an odd year for pot stocks.
- Motley Fool•17 hours ago
2 Must-Read Quotes on Marijuana From FDA Head Scott Gottlieb
Is cannabis policy reform at the federal level "inevitable?"
- Motley Fool•17 hours ago
3 Top Stocks to Buy in December
These stocks have one common denominator: Great long-term growth prospects.
- Motley Fool•17 hours ago
Why Aurora Cannabis, Canopy Growth, and Tilray Have Had a Better Year Than You Might Think
There's more to the story for these Canadian marijuana stocks' gains -- or lack thereof -- in 2018.
- Motley Fool•17 hours ago
Better Marijuana Stock: Cronos Group vs. GW Pharmaceuticals
Which stock wins in a matchup between this top Canadian marijuana grower and the biggest cannabis-focused biotech?
- Motley Fool•19 hours ago
Did Gilead Sciences Make an $11 Billion Blunder?
Spoiler alert: The answer is "no."
- Motley Fool•yesterday
Here's Why Scotts Miracle-Gro Rose 13.8% in November
The home garden specialist announced fiscal 2018 earnings and issued upbeat guidance for fiscal 2019.
- Motley Fool•2 days ago
Better Marijuana Stock: Aurora Cannabis vs. KushCo Holdings
Which stock wins in a matchup between a big marijuana producer and a top ancillary products supplier to the cannabis industry?
- Motley Fool•2 days ago
4 Multibillion-Dollar Industries Canopy Growth Thinks It Will Disrupt
Are Canopy's plans to jump into multiple huge markets only pipe dreams? Not at all.
Associated Press•2 days agoA look at where companies stand on marijuana business
When Canada legalized recreational marijuana in October, it emerged as the world leader in the industry — and U.S. companies are scrambling to get in on the action. Uruguay may have been the first country to legalize pot, but the South American country's market is dwarfed by Canada's. And while a majority of U.S. states have legalized marijuana to varying degrees, contradictory federal laws have U.S. companies reluctant to invest here. — Marlboro maker Altria Group Inc., which is headquartered in Richmond, Virginia, is paying $1.8 billion for a 45 percent stake in Cronos Group.
- Motley Fool•2 days ago
Better Buy: Scotts Miracle-Gro vs. Lowe's
There are two factors to consider when looking at Lowe's and Miracle-Gro: recent performance and marijuana.
Market Realist•2 days agoA Look at AbbVie’s Earnings Projections for 2018
On its third-quarter earnings conference call, AbbVie (ABBV) raised its adjusted EPS guidance for 2018 from its previous projection of $7.76–$7.86 to $7.90–$7.92. The revised estimate implies a YoY (year-over-year) rise of 41.3% considering the midpoint of the guidance range. As per the company’s third-quarter earnings conference call, AbbVie expects its adjusted fourth-quarter EPS to be in the range of $1.89–$1.91 excluding a $0.26 impact of noncash amortization and other items.
Market Realist•2 days agoWhy Aphria Tanked Over 11% Today
Today, Aphria (APHA)(APHQF) resumed a sharp sell-off in its stock from early this month after surging a whopping 51% yesterday. Now, let’s find out what could be driving Aphria stock down today. Grego alleged that “Aphria had diverted funds into inflated investments held by insiders.” Since then, these allegations have taken a massive toll on investors’ confidence.
- Yahoo Finance•2 days ago
Stocks tumble, crude oil surges on OPEC deal
Stock got slammed on Friday, and crude oil surged on an OPEC deal.
Market Realist•2 days agoAssessing AbbVie’s 2018 Revenue Projections
On its third-quarter earnings conference call, AbbVie (ABBV) raised its net revenue guidance for 2018 from its previous projection of $32.5 billion to $32.7 billion. The company also raised its forecast for YoY (year-over-year) operational revenue growth in 2018 from 14.5% to 15.0%. As per AbbVie’s third-quarter earnings conference call, the company expects a favorable revenue impact of less than 1% due to foreign currency fluctuations in 2018.
Associated Press•2 days agoMarlboro maker places $1.8 billion bet on marijuana
One of the world's biggest tobacco companies is diving into the cannabis market with a $1.8 billion buy-in. Marlboro maker Altria Group Inc. is taking a 45 percent stake in Cronos Group, the Canadian medical and recreational marijuana provider said Friday. The agreement includes a warrant to acquire additional shares over the next four years that could give the Altria, which is based in Richmond, Virginia, a 55 percent ownership stake in the Toronto company.
Market Realist•2 days agoAnalysts’ Recommendations for AbbVie in December
The company saw a rise of 17.53% in its share price from $80.21 on November 1 to $94.27 on November 30. Thereafter, AbbVie saw a 3.95% fall in its share price from November 30 to December 5. On November 30, AbbVie issued a press release announcing agreements that granted Pfizer (PFE) a nonexclusive global license related to Humira’s intellectual property.
- Investing.com•2 days ago
AbbVie Falls 4%
Investing.com - AbbVie (NYSE:ABBV) fell by 4.11% to trade at $86.620 by 11:29 (16:29 GMT) on Friday on the NYSE exchange.
- Market Realist•3 days ago
Short Seller Not Backing Down on Aphria
On December 6, Aphria’s (APHQF) short seller, Hindenburg Research, released its Part 2 on what it found to be further malice in the company’s acquisition efforts. According to the research, this acquisition showed a 5 million Canadian dollar gain to Aphria’s insider in a matter of six days. Further, the report pointed out that Aphria’s CEO, Vic Neufeld, was also a part of the “discount round” in which Aphria purchased companies at overpriced valuations. Even more damning was the short seller’s observation that the SEC had alleged that the individuals that Aphria purchased companies from were involved in pump and dump schemes.
- Yahoo Finance•3 days ago
Weed CEO: 'Edibles suffer from 3 major problems'
Edibles still quite aren't mainstream for various reasons, an edibles CEO tells Yahoo Finance recently on the Final Round.
- Yahoo Finance•3 days ago
Stocks tumble, oil surges on OPEC deal
Yahoo Finance's LIVE market coverage and analysis, beginning each day at 11:30 a.m. ET.
- Market Realist•3 days ago
Aphria’s Announcement of Special Committee Pauses Sell-Off
Aprhia (APHQF) recovered by nearly 50% on December 6 due to its further commitment to relieve investors’ fears related to its Latin America business. The company appointed a special committee that consists of independent directors who will be tasked with reviewing the legitimacy of the company’s acquisitions in Latin America. The above chart shows that Aphria (APHQF) is among the top ten holdings in the Horizons Marijuana Life Sciences ETF (HMMJ).
- Market Realist•3 days ago
It’s Official: Altria Acquires a Stake in Cronos Group
On December 7, Altria officially announced that it acquired a ~45% stake in the company to the tune of $1.8 billion. Given that Altria has been in the tobacco business for nearly three decades, the cannabis business makes sense for the business.
